Breast cancer among young African-American women: A summary of data and literature and of issues discussed during the "Summit Meeting on Breast Cancer Among African American Women," Washington, DC, September 8-10, 2000

Cancer

Volumn 97, Issue 1 SUPPL., 2003, Pages 273-279

  Swanson, G Marie ^a   Haslam, Sandra Z ^b   Azzouz, Faouzi ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

African Americans; Breast cancer; Disparities; Young women

Indexed keywords

CAROTENOID; CONTRACEPTIVE AGENT; CRYPTOXANTHIN; ESTROGEN; ESTROGEN RECEPTOR; LYCOPENE; PROGESTERONE; PROGESTERONE RECEPTOR; XANTHOPHYLL; ZEAXANTHIN;

ADULT; ADVANCED CANCER; AXILLARY LYMPH NODE; BODY HEIGHT; BODY WEIGHT; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CANCER TISSUE; CAUCASIAN; CONFERENCE PAPER; CULTURAL FACTOR; DIET; ETHNOLOGY; FEMALE; GENETICS; HISTOLOGY; HODGKIN DISEASE; HORMONE ACTION; HUMAN; LOWEST INCOME GROUP; LYMPHOMA; MEDICAID; METASTASIS; NEGRO; OBESITY; PARITY; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RACE DIFFERENCE; RISK FACTOR; THYROID CANCER; TUMOR DIFFERENTIATION; TUMOR GROWTH;

EID: 0037214912     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11025     Document Type: Conference Paper

References (48)

1. Surveillance, Epidemiology, and End Results Program. SEER* Stat 3.0. Bethesda: National Cancer Institute, 2000.
2. Aebi S, Gelber S, Castiglione-Gertsch M, et al. Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet. 2000;355:1869-1874.
3. Chung M, Chang HR, Bland KI, Wanebo HJ. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 1996;77:97-103.
4. Dignam JJ. Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin. 2000;50:50-64.
5. Dignam JJ, Redmond CK, Fisher, Costantino JP, Edwards BK. Prognosis among African-American women and white women with lymph node negative breast carcinoma. Cancer. 1997;80:80-90.
6. El-Tamer MB, Homel P, Wait RB. Is race a poor prognostic factor in breast cancer? J Am Coll Surg. 1999;89:41-45.
7. Feldman AI, Welch JP. Long-term outcome in women less than 30 years of age with breast cancer. J Surg Oncol. 1998; 68:193-198.
8. Kim SH, Simkovich-Heerdt A, Trank KN, Maclean B, Borgen PI. Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy. J Am Coll Surg. 1998;187:1-8.
9. Swanson GM, Lin C-S. Survival patterns among younger women with breast cancer: The effects of age, race, stage, and treatment. J Natl Cancer Inst Monogr. 1994;16:69-77.
10. Walker RA, Lees E, Webb MB, Dearing SJ. Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer. 1996;74:1796-1800.
11. Winchester DP, Osteen RT, Menck HR. The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer. 1996;78:1838-1843.
12. Wingo PA, Ries LAG, Parker SI, Health CW. Long-term cancer patient survival in the United States. Cancer Epidemiol Biomarkers Prev. 1998;7:271-282.
13. Gann P, Colilla SA, Gapstur SM, et al. Factors associated with axillary lymph node metastasis from breast carcinoma: Descriptive and predictive analyses. Cancer. 1999;86:1511-1519.
14. Aisenberg AC, Finkelstein DM, Doppke KP, et al. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer. 1997;79:1203-1210.
15. Broeks A, Russell NS, Floore AN, et al. Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations. Int J Radiat Biol. 2000;76:693-698.
16. Cutuli B, Dhermain F, Borel C, et al. Breast cancer in patients treated for Hodgkins' disease. Eur J Cancer. 1997;33: 2315-2320.
17. Kaste SC, Hudson MM, Jones DJ, et al. Breast masses in women treated for childhood cancer: Incidence and screening guidelines. Cancer. 1998;82:784-792.
18. Pratap R, Shousha S. Breast carcinoma in women under the age of 50: Relationship between p53 immunostaining, tumour grade, and axillary lymph node status. Breast Cancer Res Treat. 1998;49:35-39.
19. Vassilopoulou-Sellin R, Palmer I, Taylor S, Cooksley CS. Incidence of breast carcinoma in women with thyroid carcinoma. Cancer. 1999;85:696-705.
20. Coates RJ, Uhler RJ, Hall HI, et al. Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood. Br J Cancer. 1999;81:167-174.
21. Peacock SL, White E, Daling JR, Voight LF, Malone KE. Relation between obesity and breast cancer in young women. Am J Epidemiol. 1999;149:339-346.
22. Potischman N, Weiss HA, Swanson CA, et al. Diet during adolescence and risk of breast cancer among young women. J Natl Cancer Inst. 1998;90:226-233.
23. Weiss HA, Troisi R, Rosing MA, et al. Fertility problems and breast cancer risk in young women: A case-control study in the United States. Cancer Causes Control. 1998;9:331-339.
24. Dorgan JF, Sowell A, Swanson CA, et al. Relationships of serum carotenoids, retinal a-tocopherol, and selenium with breast cancer risk. Cancer Causes Control. 1998;9:89-97.
25. Garland M, Hunter DJ, Colditz GA, et al. Alcohol consumption in relation to breast cancer risk in a cohort of United States women 25-42 years of age. Cancer Epidemiol Biomarkers Prev. 1999;8:1017-1021.
26. Viel J-F, Perarnau J-M, Challier B, Faivre-Nappez I. Alcoholic calories, red wine consumption and breast cancer among premenopausal women. Eur J Epidemiol. 1997;13:639-643.
27. Koprowski C, Ross RK, Mack WJ, Henderson BE, Bernstein L. Diet, body size and menarche in a multiethnic cohort. Br J Cancer. 1999;79:1907-1911.
28. Rockhill B, Moorman PG, Newman B. Age at menarche, time to regular cycling, and breast cancer. Cancer Causes Control. 1998;9:447-453.
29. Ursin G, Ross RK, Sullivan-Halley J, et al. Use of oral contraceptives and risk of breast cancer in young women. Breast Cancer Res Treat. 1998;50:175-184.
30. Tryggvadottir I, Tulinius H, Gudmundsdottir GB. Oral contraceptive use at a young age and the risk of breast cancer: An Icelandic, population-based cohort study of the effect of birth year. Br J Cancer. 1997;75:139-143.
31. Gammon MD, Hibshoosh H, Terry MB, et al. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women. Cancer Epidemiol Biomarkers Prev. 1999;8:413-419.
32. Pathak DR, Osuch JR, Jianping H. Breast carcinoma etiology: Current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations. Cancer 2000;88 (Suppl):1230-1238.
33. Anderson BO, Petrek JA, Byrd DR, et al. Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger. Ann Surg Oncol. 1996;3:204-211.
34. Koduri S, Fuqua SA, Poola I. Alterations in the estrogen receptor alpha mRNA in the breast tumors of African-American women. J Cancer Res Clin Oncol. 2000;126:291-297.
35. Dunning AM, Healey CS, Pharaoh PD, et al. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Br J Cancer. 1998;77:2045-2047.
36. Feigelson HS, Shames LS, Pike MC, et al. Cytochrome P450calpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res. 1998;58:585-587.
37. Fitzgerald MG, MacDonald DJ, Krainer M, et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med. 1996;334:143-149.
38. Gentile M, Olsen K, Dufmats M, Wingren S. Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: Association with poor survival. Br J Cancer. 1999;80:843-849.
39. Helzlsouer KJ, Huang HY, Strickland PT, et al. Association between CYP17 polymorphisms and the development of breast cancer. Cancer Epidemiol Biomarkers Prev. 1998;7: 945-949.
40. Krainer M, Silva-Arrieta S, Fitzgerald MG, et al. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med. 1997;336:1416-1421.
41. Bailey LR, Roodi N, Dupont WD, Parl FF. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res. 1998;58:5038-5041.
42. Malone KE, Daling JR, Neal C, et al. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer. 2000;88:1393-1402.
43. Malone KE, Daling JR, Weiss NS, et al. Family history and survival of young women with invasive breast carcinoma. Cancer. 1996;78:1417-1425.
44. Shen D, Wu Y, Subbarao M, et al. Mutation analysis of BRCA1 gene in African-American patients with breast cancer. J Natl Med Assoc. 2000:92:29-35.
45. Taioli E, Trachman J, Chen X, et al. A CYP1A1 fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res. 1995;55:3757-3758.
46. Bradley C, Given CW, Roberts C. Disparities in cancer diagnosis and survival. Cancer. 2001;91:178-188.
47. Lannin DR, Mathews HF, Mitchel J, et al. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998;279: 1801-1807.
48. Brinton LA, Benichou J, Gammon MD, et al. Ethnicity and variation in breast cancer incidence. Int J Cancer: 1997;73: 349-355.